Mednet Logo
HomeQuestion

How would you approach patients with high risk mucoepidermoid carcinoma (high grade) of the parotid gland for optimal adjuvant treatment?

1
5 Answers
Mednet Member
Mednet Member
Medical Oncology · Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

Would be nice to know all the risk factors - margins, PNI, etc.

Due to high-risk features, adjuvant RT is appropriate and guideline-concordant

However, there is no strong supporting evidence to add adjuvant chemo as salivary gland cancers are typically not chemo-sensitive.

Published real-world data suc...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Johns Hopkins University School of Medicine

The question of adjuvant therapy for this high-grade mucoepidermoid cancer is reasonable but I am in agreement with others that RT alone is the appropriate and evidence-based management in this case. Guidance from published literature consists mainly of retrospective case series that are heterogeneo...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

Postop RT. 60 Gy/30 fractions for R0, 66/33 for R1, 70/35 for R2 margins

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · University of Michigan Medical School

I agree. Data does not yet support radio sensitization for salivary gland tumors.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · The Oncology Institute of Hope and Innovation

RT alone

Register or Sign In to see full answer